These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 18769331)
1. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile. Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331 [TBL] [Abstract][Full Text] [Related]
2. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases. Fadare O; Dadmanesh F; Alvarado-Cabrero I; Snyder R; Stephen Mitchell J; Tot T; Wang SA; Ghofrani M; Eusebi V; Martel M; Tavassoli FA Am J Surg Pathol; 2006 Nov; 30(11):1445-53. PubMed ID: 17063087 [TBL] [Abstract][Full Text] [Related]
3. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset? Fadare O; Wang SA; Hileeto D Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623 [TBL] [Abstract][Full Text] [Related]
4. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma. Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P Breast J; 2005; 11(4):278-80. PubMed ID: 15982396 [TBL] [Abstract][Full Text] [Related]
5. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964 [TBL] [Abstract][Full Text] [Related]
6. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
7. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Wahed A; Connelly J; Reese T Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484 [TBL] [Abstract][Full Text] [Related]
8. Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis. Carder PJ; Shaaban A; Alizadeh Y; Kumarasuwamy V; Liston JC; Sharma N Histopathology; 2010 Sep; 57(3):472-8. PubMed ID: 20727019 [TBL] [Abstract][Full Text] [Related]
9. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised? Kunju LP; Kleer CG Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049 [TBL] [Abstract][Full Text] [Related]
10. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750 [TBL] [Abstract][Full Text] [Related]
11. Expression of ERalpha and ERbeta in lobular carcinoma in situ. Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077 [TBL] [Abstract][Full Text] [Related]
12. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value. Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111 [TBL] [Abstract][Full Text] [Related]
13. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Steinman S; Wang J; Bourne P; Yang Q; Tang P Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367 [TBL] [Abstract][Full Text] [Related]
14. Pleomorphic lobular carcinoma in situ of the breast composed almost entirely of signet ring cells. Fadare O Pathol Int; 2006 Nov; 56(11):683-7. PubMed ID: 17040292 [TBL] [Abstract][Full Text] [Related]
15. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811 [TBL] [Abstract][Full Text] [Related]
16. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [TBL] [Abstract][Full Text] [Related]
17. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics. Yu J; Dabbs DJ; Shuai Y; Niemeier LA; Bhargava R Am J Clin Pathol; 2011 Jul; 136(1):88-97. PubMed ID: 21685036 [TBL] [Abstract][Full Text] [Related]
18. Lobular carcinoma in situ/atypical lobular hyperplasia on breast needle biopsies: does it warrant surgical excisional biopsy? A study of 27 cases. O'Neil M; Madan R; Tawfik OW; Thomas PA; Fan F Ann Diagn Pathol; 2010 Aug; 14(4):251-5. PubMed ID: 20637429 [TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
20. Lobular neoplasia in breast core needle biopsy specimens is associated with a low risk of ductal carcinoma in situ or invasive carcinoma on subsequent excision. Renshaw AA; Derhagopian RP; Martinez P; Gould EW Am J Clin Pathol; 2006 Aug; 126(2):310-3. PubMed ID: 16891208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]